A U-M study of pancreatic cancer surgeries suggests experience with related procedures could help when setting volume standards for relatively rare operations.
Clinical Trial Offers Clues About Why Some Metastatic Prostate Cancers Don’t Respond to Anti-Androgen Therapy
Transcriptional profiling identifies a gene program active in metastatic prostate cancers that failed to respond to enzalutamide treatment.
From a negative pressure helmet to enhanced protocols, investigators are adapting their research to focus on the COVID-19 pandemic.
U-M study combines local data with data from The Cancer Genome Atlas to discover novel biomarkers for chromophobe renal cell carcinoma through next-generation RNA sequencing.